TR200002786T2 - Meloksikam için yeni galenik bir formülasyon. - Google Patents

Meloksikam için yeni galenik bir formülasyon.

Info

Publication number
TR200002786T2
TR200002786T2 TR2000/02786T TR200002786T TR200002786T2 TR 200002786 T2 TR200002786 T2 TR 200002786T2 TR 2000/02786 T TR2000/02786 T TR 2000/02786T TR 200002786 T TR200002786 T TR 200002786T TR 200002786 T2 TR200002786 T2 TR 200002786T2
Authority
TR
Turkey
Prior art keywords
meloxicam
galenic formulation
new galenic
manufacture
new
Prior art date
Application number
TR2000/02786T
Other languages
English (en)
Inventor
Thomas Bock Dr.
Sagm�Ller Paul
Peter Sieger Dr.
Dietrich T�Rck Dr.
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of TR200002786T2 publication Critical patent/TR200002786T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bulusun konusu, agiz yoluyla uygulanan, içindeki etkin maddenin hizla serbest birakildigi ve emildigi bir ilaç biçiminin imalatina yönelik olarak anorganik ya da organik bir baz kaynakli meloksikam tuzunun, agri tedavisindeki kullanimi, dogrudan tablet olusturma yoluyla üretilebilen ilgili ilaç biçimleri ve bunlarin imalatina yönelik yöntemdir.
TR2000/02786T 1998-03-27 1999-03-23 Meloksikam için yeni galenik bir formülasyon. TR200002786T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105569A EP0945134A1 (de) 1998-03-27 1998-03-27 Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation

Publications (1)

Publication Number Publication Date
TR200002786T2 true TR200002786T2 (tr) 2001-01-22

Family

ID=8231652

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02786T TR200002786T2 (tr) 1998-03-27 1999-03-23 Meloksikam için yeni galenik bir formülasyon.

Country Status (25)

Country Link
US (1) US6869948B1 (tr)
EP (2) EP0945134A1 (tr)
JP (1) JP3639532B2 (tr)
KR (1) KR100589299B1 (tr)
CN (1) CN1163231C (tr)
AR (1) AR016197A1 (tr)
AT (1) ATE254920T1 (tr)
AU (1) AU762322C (tr)
BR (1) BR9909192A (tr)
CA (1) CA2326517C (tr)
DE (1) DE59907871D1 (tr)
DK (1) DK1083902T3 (tr)
ES (1) ES2212547T3 (tr)
HK (1) HK1034183A1 (tr)
HU (1) HUP0101246A3 (tr)
IL (2) IL137652A0 (tr)
NO (1) NO326852B1 (tr)
NZ (1) NZ507382A (tr)
PL (1) PL192967B1 (tr)
PT (1) PT1083902E (tr)
TR (1) TR200002786T2 (tr)
TW (1) TWI236914B (tr)
UY (1) UY25441A1 (tr)
WO (1) WO1999049867A1 (tr)
ZA (1) ZA200004178B (tr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69929635T2 (de) * 1998-12-01 2006-09-21 Dr. Reddy's Research Foundation, Hyderabad Neue pharmazeutische zusammenstellung und deren herstellungsprozess
AU1548001A (en) 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
WO2001091751A1 (en) * 2000-05-30 2001-12-06 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AU2001260083A1 (en) * 2000-05-26 2001-12-03 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US7120656B1 (en) 2000-10-04 2006-10-10 Marvell International Ltd. Movable tap finite impulse response filter
CZ20032568A3 (cs) * 2001-02-27 2004-04-14 Ranbaxy Laboratories Limited Rychle rozpustné tablety enzymového inhibitoru cyklooxygenázy-2
EP1250921A1 (en) * 2001-04-21 2002-10-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Fast disintegrating meloxicam tablet
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (en) * 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Meloxicam suppositories
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
DK1839654T3 (da) 2002-11-22 2010-08-16 Gruenenthal Gmbh Anvendelse af (1R, 2R)-3-(3-dimenthylamino-1-ethyl-2-methylpropyl)- phenol til behandling af betændelsessmerte
US8512727B2 (en) 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
CA2519432C (en) * 2003-03-17 2009-06-09 Japan Tobacco Inc. Pharmaceutical compositions comprising cetp inhibitors and a water-insoluble concentration-enhancing additive for the treatment of cardiovascular disease
KR100620239B1 (ko) * 2004-01-05 2006-09-13 신일제약주식회사 용해도 및 안정성이 향상된 경구투여용 멜록시캄 고형제조성물
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US20060025408A1 (en) * 2004-08-02 2006-02-02 Sundaram Venkataraman Process for the preparation of crystalline form-1 of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
PL3056492T3 (pl) 2004-10-08 2022-03-21 Abbvie Inc. Sól megluminowa i jej krystaliczne postaci leku (delafloksacyna)
HU227359B1 (en) * 2004-12-18 2011-04-28 Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag Process for producing meloxicam and meloxicam potassium salt of high purity
CA2586288A1 (en) 2004-12-06 2006-06-15 Janssen Pharmaceutica Nv Oral suspension comprising meloxicam
US8097614B2 (en) 2005-02-17 2012-01-17 Velcera Pharmaceuticals, Inc. Transmucosal administration of meloxicam compositions for treating and preventing disorders in non-human domesticated animals
CN101222911A (zh) * 2005-07-15 2008-07-16 特瓦制药工业有限公司 新的制粒方法及由此制备的颗粒
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
US20070154542A1 (en) * 2005-12-30 2007-07-05 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
US8124603B2 (en) * 2008-01-22 2012-02-28 Thar Pharmaceuticals In vivo studies of crystalline forms of meloxicam
TR200809200A1 (tr) 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
PL2488145T3 (pl) 2009-10-12 2024-08-26 Boehringer Ingelheim Vetmedica Gmbh Pojemniki na kompozycje zawierające meloksykam
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2012009542A2 (en) 2010-07-14 2012-01-19 Kansas State University Research Foundation Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
CN113614077A (zh) * 2018-11-05 2021-11-05 迈兰实验室有限公司 美洛昔康共晶
CN113710231A (zh) 2019-04-22 2021-11-26 麦兰专业有限合伙公司 美洛昔康共晶组合物
AU2021375409A1 (en) 2020-11-06 2023-06-29 Mylan Laboratories Ltd Pharmaceutical composition comprising meloxicam
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
AU730495B2 (en) * 1995-11-13 2001-03-08 North West University Administration media for analgesic, antiinflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
EP1007049A1 (en) * 1997-08-27 2000-06-14 Hexal AG New pharmaceutical compositions of meloxicam with improved solubility and bioavailability

Also Published As

Publication number Publication date
PT1083902E (pt) 2004-04-30
JP2002509886A (ja) 2002-04-02
EP1083902A1 (de) 2001-03-21
ZA200004178B (en) 2002-04-24
DK1083902T3 (da) 2004-03-29
NO20004823L (no) 2000-11-22
CA2326517A1 (en) 1999-10-07
AU762322B2 (en) 2003-06-26
CA2326517C (en) 2008-06-10
EP1083902B1 (de) 2003-11-26
ATE254920T1 (de) 2003-12-15
PL192967B1 (pl) 2006-12-29
AR016197A1 (es) 2001-06-20
NO20004823D0 (no) 2000-09-26
PL342988A1 (en) 2001-07-16
JP3639532B2 (ja) 2005-04-20
HK1034183A1 (en) 2001-10-19
UY25441A1 (es) 1999-11-17
IL137652A (en) 2006-10-05
HUP0101246A2 (hu) 2002-05-29
US6869948B1 (en) 2005-03-22
AU762322C (en) 2004-02-12
TWI236914B (en) 2005-08-01
NO326852B1 (no) 2009-03-02
KR100589299B1 (ko) 2006-06-14
IL137652A0 (en) 2001-10-31
NZ507382A (en) 2003-08-29
EP0945134A1 (de) 1999-09-29
ES2212547T3 (es) 2004-07-16
AU3417199A (en) 1999-10-18
KR20010034698A (ko) 2001-04-25
CN1163231C (zh) 2004-08-25
HUP0101246A3 (en) 2002-08-28
CN1295478A (zh) 2001-05-16
DE59907871D1 (de) 2004-01-08
BR9909192A (pt) 2000-12-05
WO1999049867A1 (de) 1999-10-07

Similar Documents

Publication Publication Date Title
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20065904L (no) Terapeutiske forbindelser
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
SE9900961D0 (sv) Novel compounds
AR032293A1 (es) Estuche farmaceutico
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
GB0222514D0 (en) Organic compounds
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
SE9802208D0 (sv) Novel compounds
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
SE9802209D0 (sv) Novel compounds
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
GEP201606538B (en) Preoperative treatment of post operative pain
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний